Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study is testing a new injectable drug called TQB6411 for people with advanced lung cancer. The main goals are to find the safest and most effective dose and to see how well the drug shrinks tumors and controls the cancer. It will involve about 465 participants who meet spec…

This is a first-in-human study to test the safety and find the right dose of a new drug called TQB3142 for people with advanced cancers that have stopped responding to standard treatments. The main goal is to see how much of the drug the body can handle, what side effects occur, …

This study aims to check the safety of an inhaled medicine called TQC3721 for people with moderate to severe COPD, a serious lung disease. It will enroll 800 patients who will use the medicine for 48 weeks while researchers monitor for side effects and track breathing problems. T…

This large, late-stage trial is testing whether a new inhaled medicine called TQC3721 can help people with moderate-to-severe COPD breathe better and have fewer serious flare-ups. About 666 adults aged 40-80 with a significant smoking history will use the inhaler or a placebo for…

This study is testing whether an oral capsule called TQ-B3234 can shrink painful, inoperable tumors in adults with neurofibromatosis type 1 (NF1). It will compare the drug to a placebo (a dummy pill) in 177 participants over 24 weeks to see if it reduces tumor size and improves p…

This early-stage study is testing a new oral medication called TQB3201 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking treatments. The main goals are to find a safe dose, see how the body processes the drug, and get a…

This is the first time a new oral drug called TQB3217 is being tested in people. The main goal is to find a safe dose and see how the body processes it in 40 adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will also get an early …

This early study aims to understand how a single dose of the experimental drug TQ05105 is processed by the body in people with mild or moderate liver problems, compared to healthy people. It will involve 24 adults to measure drug levels in the blood and check for safety. The goal…